CompanyIndiaUpdated May 5, 2026
Alkemi Growth Capital

Alkemi Growth Capital

Alkemi Growth Capital: Investor • focus on Venture Capital, Impact • active in India, Asia • offices in India • AUM $34M.

Never miss breaking news

Get instant notifications when new news matching "Alkemi Growth Capital" are published.

Company Profile

Alkemi Growth Capital is an India-focused early-stage venture capital firm dedicated to investing in the health and wellness sector. The firm's core mission is to elevate the health and well-being of Indian consumers while simultaneously maximizing returns for its shareholders. Alkemi Growth Capital focuses on scalable companies that have demonstrated product-market fit, possess governance-aligned leadership, and exhibit a clear pathway to institutional scale. Their investment strategy emphasizes sector specialization, high-conviction portfolio construction, and long-term partnership capital to accelerate market-leading companies with transformative potential in the healthcare ecosystem.

The firm was formally incorporated as an LLP on March 27, 2019, though its founding partners, led by Alka Goel, launched the firm in 2017 to specifically target healthcare startups in India. Alka Goel, the Founding and Managing Partner, is recognized as a prominent figure for women in venture capital within the Indian startup ecosystem. She is joined by Dr. Mansi Aggarwal, a Partner with expertise in healthcare and investment strategies, contributing to Alkemi's focus on impactful healthcare solutions. The firm's leadership and team bring diverse backgrounds and a commitment to supporting bold and determined founders.

Alkemi Growth Capital has built a diverse portfolio of companies across various stages, primarily focusing on Series A and Series C investments. Notable active portfolio companies include Redcliffe Labs, a leading diagnostic network; Uncover, specializing in single-specialty dermatology clinics; Docquity, a large healthcare professional network across Southeast Asia; Medkart, a retail pharmacy chain promoting affordable generic medicines; and Farmley, a healthy snacking brand. The firm also supports innovations in areas like oncology diagnostics (Datar Cancer Genetics), tech-enabled emergency response (Medulance), and healthcare recruitment (Jobizo).

The firm actively engages with its portfolio companies, offering tailored support in areas such as process stabilization, revenue expansion through its global network, fiscal prudence, and facilitating follow-on capital. Alkemi Growth Capital believes in providing thought partnership to sharpen core value drivers and enhance structures for faster, high-quality decisions. With approximately $34 million in assets under management from its first fund, the firm is currently raising its second fund, which has achieved a first close of around $50 million towards a target of $75 million.

News & Signals (0)

No linked news activity found for this company.

Investor Listings

Similar Companies

Ranked by shared taxonomies: sector, subsector, geography, asset class and investor lists.

No similar companies found with overlapping taxonomy tags.